2019 International Congress Archives - Page 4 of 217

Saccade profiles in Tourette syndrome

Y. Sugiyama, H. Fukuda, Y. Terao, S. Tokushige, K. Hoshino, M. Hamada, Y. Ugawa, T. Toda (Tokyo, Japan)
Safety and effectiveness of levodopa-carbidopa intestinal gel for advanced Parkinson’s disease : a large single-center study

A-S. Blaise, G. Baille, N. Carrière, D. Devos, K. Dujardin, G. Grolez, A. Kreisler, M. Kyheng, C. Moreau, E. Mutez, D. Seguy, L. Defebvre (Lille, France)
Safety and Tolerability in Parkinson’s Disease Patients Treated with a Continuous Subcutaneous Infusion of ABBV-951: Design of a 52-Week Phase 3 Study

M. Facheris, J. Benesh, J. Streit, W. Robieson, C. Zadikoff, D. Standaert (North Chicago, IL, USA)
Safety and Tolerability of Apomorphine Sublingual Film During Maintenance Treatment in Patients With Parkinson’s Disease and “OFF” Episodes: A Pooled Analysis

W. Ondo, A. Ellenbogen, S. Isaacson, A. Espay, C. Singer, P. Bhargava, M. Worden, D. Blum, B. Navia (Houston, TX, USA)
Safety and Tolerability of opicapone in Parkinson’s disease

M. Campins Romeu, M. Losada López, I. Sastre Bataller, MJ. Pérez García, I. Martínez Torres (Valencia, Spain)
Safety of Bone marrow-derived Allogeneic Mesenchymal Stem Cells in Parkinson’s disease Patients

M. Schiess, J. Suescun, T. Ellmore, MF. Doursout, E. Furr -Stimming, Z. Mei, A. Gee (Houston, TX, USA)
Safety of Gocovri in Clinical Practice: One-year Post-launch Pharmacovigilance Data

C. Tanner, R. Pahwa, V. Vandevoorde, K. Wehrman, R. Elfont (San Francisco, CA, USA)
Safety of Iron Chelation in Patients with Brain Iron Overload

C. Fradette, T. Klopstock, L. Neumayr, I. Karin, G. Zorzi, T. Kmieć, B. Büchner, H. Steele, R. Horvath, P. Chinnery, A. Basu, C. Küpper, C. Neuhofer, F. Zibordi, N. Nardocci, A. Stilman, M. Spino, E. Vichinsky, F. Tricta (Toronto, ON, Canada)
Safinamide ameliorates motor deficits and plastic alterations before the onset of L-DOPA-induced dyskinesia in a rat model of Parkinson’s disease

M. Sciaccaluga, P. Mazzocchetti, G. Bastioli, V. Ghiglieri, B. Picconi, A. Tozzi, C. Caccia, C. Keywood, G. Padoani, P. Calabresi (Perugia, Italy)
Safinamide improves motor symptoms severity and daily living in Parkinson’s Disease (PD) patients

C. Cattaneo, E. Bonizzoni, C. Keywood (Milan, Italy)
SAFINAMIDE IN DAILY CLINICAL PRACTICE: ASSESSMENT OF EFFICACY AND TOLERABILITY IN PARKINSON´S DISEASE

A. Vinagre-Aragón, E. Mondragón-Rezola, I. Croitoru, A. Bergareche-Yarza, JJ. Poza-Aldea, A. Olaskoaga-Caballer, M. Iridoy-Zulet, M. Ruibal-Salgado, JC. Gómez-Esteban, K. Berganzo-Corrales, B. Tijero-Merino, J. Ruiz-Martínez (San Sebastián, Spain)
Safinamide in the treatment of URINARY symptoms in PARKinson’s disease (SURINPARK)

A. Gómez López, I. Pareés Moreno, S. Fanjul Arbós, JL. López Sendon, JC. Martínez Castrillo, A. Alonso Cánovas (Madrid, Spain)
Safinamide reduces membrane excitability and synaptic transmission of striatal spiny projection neurons in a rat model of Parkinson’s disease

A. Tozzi, M. Sciaccaluga, P. Mazzocchetti, G. Bastioli, V. Ghiglieri, B. Picconi, C. Caccia, C. Keywood, G. Padoani, P. Calabresi (Perugia, Italy)
Safinamide: real world evidence in Toledo´s Movement Disorders Unit

N. López-Ariztegui, MI. Morales-Casado, JC. Segundo-Rodríguez, A. Avila-Fernández, N. García-Alvarado, J. Pérez-Matos (Toledo, Spain)
Satisfaction with care in late stage Parkinson’s disease

K. Rosqvist, P. Hagell, S. Iwarsson, M. Nilsson, P. Odin (Lund, Sweden)
Scene Induced emotion processing in Parkinson’s disease: BOLD-fMRI study

S. Boujraf, M. Benzagmout, B. Alami, H. Amadou, H. El Hamdaoui, A. Bennani, M. Jaafari, I. Rammouz, M. Maaroufi, D. Boussaoud (Fez, Morocco)
Screening of mutations in PARK2 gene and Dopamine levels in Parkinson’s disease (PD) patients in Coimbatore population, India

B. Vellingiri, D. Venkatesan (Coimbatore, India)
Searching for the optimal functional target for deep brain stimulation in Essential Tremor

D. Kübler, B. Al-Fatly, D. Kroneberg, S. Ewert, C. van Riesen, G-H. Schneider, A. Horn, A. Kühn (Berlin, Germany)
Seeking regulatory feedback on novel clinical outcome assessments: a case example from the Huntington’s Disease – Regulatory Science Consortium (HD-RSC)

A. Mullin, R. Fuller, G. Stebbins, J. Stout, A. Robbins, P. Feigenbaum, M. Roche, E. Gantman, C. Sampaio, M. Brumfield (Tucson, AZ, USA)
Selective Disinhibition of Thalamus by Globus Pallidus Internus: Failure of a Normal Control Mechanism in Childhood Dystonia

T. Sanger, E. Arguelles, M. Liker (Los Angeles, CA, USA)
Self-report of cognitive functional abilities is inaccurate in PD-MCI and PDD

S. Holden, L. Medina, A. Simpson, B. Kluger (Aurora, CO, USA)
Self-reported demographic, genetic, symptom, and treatment data of subjects in the Fox Trial Finder

M. Bailey, A. Gera, Y. Liu, B. Ouyang, G. Pal (Chicago, IL, USA)
Self-reported substance abuse in a real-world sample of Tourette Syndrome and other tic disorder subjects

W. Deeb, A. Elkouzi, I. Malaty (Gainesville, FL, USA)
Semantic fluency impairment and amygdala atrophy are predictive factors for the development of Parkinson’s disease dementia

O. Cousins, G. Pagano, J. Schulz, G. Dervenoulas, H. Wilson, S. Caminiti, S. Polychronis, M. Politis (London, United Kingdom)
Semantic Memory Assessment in Parkinson’s Disease

J. Cardona, F. Marmolejo-Ramos, C. Trujillo, M. Larson (Santiago de Cali, Colombia)
Sensitivity of magnetic resonance imaging findings in the diagnosis of progressive supranuclear palsy

L. Marques, V. Silva, J. Araújo, S. Varanda, G. Carneiro, M. Rodrigues (Braga, Portugal)
Sequencing of single human nigral dopaminergic neurons for somatic copy number variants

D. Perez-Rodriguez, M. Kalyva, S. Santucci, K. Mokretar, M. Leija-Salazar, A. Schapira, T. Lashley, J. Holton, C. Proukakis (London, United Kingdom)
Serological analysis of circulating Alpha Synuclein protein levels by Surface Plasmon Resonance (SPR) In Parkinson’s disease

A. Singh, T. Bajaj, A. Dey, S. Dey (New Delhi, India)
Serotonergic function in De Novo Parkinson’s Disease

HK. Park, JJ. Lee, YM. Park (Goyang, Republic of Korea)
Serum Inflammatory Profile for the Discrimination of tremor severity in essential tremor

Z. Muruzheva, D. Traktirov, I. Ivleva, V. Maystrenko, M. Karpenko (Saint-Petersburg, Russian Federation)
Serum MIR-96-5P and MIR-339-5P as a Potential Biomarker for Multiple System Atrophy and Parkinson’s Disease

A. Vallelunga, T. Iannitti, S. Capece, G. Somma, G. Dati, P. Barone, W. Meissner, M. Pellecchia (Salerno, Italy)
Serum mucosal chemokine levels in patients with Parkinson disease.

S. Haji, W. Sako, N. Murakami, Y. Osaki, Y. Izumi (Tokushima, Japan)
Serum non-mercaptalbumin as a potential biomarker in Parkinson’s disease and related disorders

S. Ueno, T. Hatano, A. Okuzumi, S. Saiki, Y. Oji, A. Mori, T. Koinuma, M. Fujimaki, H. Takeshige-Amano, K. Yasukawa, Y. Yatomi, H. Ikeda, N. Hattori (Tokyo, Japan)
Serum uric acid level as a biomarker in sporadic and familial (p.A53T alpha synuclein carriers) Parkinson’s disease: Longitudinal data from the PPMI study

C. Koros, AM. Simitsi, M. Stamelou, D. Papadimitriou, A. Bougea, I. Pachi, N. Papagiannakis, A. Prentakis, E. Angelopoulou, R. Antonellou, M. Bozi, X. Geronicola Trapali, L. Stefanis (Athens, Greece)
Serum uric acid levels and cognitive function in Parkinson’s disease

J. Difrancisco-Donoghue, W. Werner, B. Krishnamachari, K. Arabian, E. Thomas, D. Granger, R. Gallagher (Irvine, CA, USA)
Severe hypomimia in drug naïve Parkinson´s disease patients may predict mild cognitive impairment

C. Gasca-Salas, L. Vela, J. Obeso (Alcorcón, Spain)
Severity of REM sleep without atonia (RSWA) correlates with cognitive functions in patients with REM sleep behaviour disorder (RBD)

M. Figorilli, P. Pisanu, M. Mascia, M. Meloni, R. Lecca, G. Gioi, P. Congiu, L. Tamburrino, G. Defazio, ML. Fantini, M. Puligheddu (Monserrato, Italy)
Sex-specific effect of ATXN2 rs7969300 polymorphism on age at onset in Spinocerebellar Ataxia type 2

L. Almaguer-Mederos, S. Gispert, D. Almaguer-Gotay, R. Aguilera-Rodríguez, Y. González-Zaldívar, Y. Vázquez-Mojena, D. Cuello-Almarales, D. Palenzuela, G. Auburger (Havana, Cuba)
Sexual Needs & function assessment of patients with Parkinson’s disease in the tertiary movement disorder’s center

S. Peleg Nesher, Y. Manor, A. Rosenberg, S. Naor, T. Taichman, A. Ezra, D. Roque, J. Shurer, D. Drazheva, N. Browner, K. Robertson, T. Gurevich (Tel Aviv, Israel)
Shaking Palsy of the Larynx – a Potential Biomarker for Multiple System Atrophy

F. Gandor, A. Vogel, S. Ahring, D. Gruber, HJ. Heinze, R. Dziewas, G. Ebersbach, T. Warnecke (Beelitz-Heilstaetten, Germany)
Share the Care: Supporting Parkinson’s Disease Caregivers Through Peer Mentoring

J. Lee, E. Wallace, C. Niemet, S. Hess, B. Ouyang, J. Wilkinson, D. Hall, J. Chodosh, J. Fleisher (Philadelphia, PA, USA)
Shedding light on the relationship between dyskinesia assessed by a wearable device and impulsive compulsive behaviour in Parkinson’s disease

F. Morgante, A. de Angelis, C. Siri, M. Horne, A. Leake, D. Paviour, M. Edwards, L. Ricciardi (London, United Kingdom)
Short term use of bromocriptine for treatment of Parkinson’s disease during pregnancy

D. Taylor, P. Lewitt (West Bloomfield, MI, USA)
Shower Shock: Directional Lead Malfunction in a Patient with Vim DBS

H. Lu, A. Garland Bacerra, E. Hogg, A. Perilla, A. Mamelak, M. Tagliati (Los Angeles, CA, USA)
Shuffling gait may be pitfall in neurological examination in Parkinson’s disease

J. Park, HT. Kim (Seoul, Republic of Korea)
Sick leaves in the years preceding the diagnosis of Parkinson’s disease: a nationwide case-control study in France

F. Moisan, L. Mandereau-Bruno, E. Moutengou, L. Carcaillon-Bentata, A. Elbaz (Saint-Maurice, France)
Simple Partial Status Epilepticus Presenting With Dystonic Features In Acute Stroke

T. Ali, S. Pradeep, D. Ginupally, Z. Guduru (Lexington, KY, USA)
Singing – tune into self-regulation: A holistic system perspective

E. Wünnenberg, M. Jungen (Frankfurt Am Main, Germany)
Single Centre Experience of PEG Feeding in Parkinson’s Disease

H. Fairclough, H. Bashir, R. Beekman, M. Lee, E. Johns, C. Mcdonald (Gateshead, United Kingdom)
Skin could be the new peripheral tissue of interest in Parkinson’s disease transcriptomics

A. Planken, P. Taba, S. Kõks, KM. Kasterpalu, L. Kadastik-Eerme, F. Lättekivi, L. Kurvits, E. Reimann (Tartu, Estonia)
Skin in the game: Small fiber neuropathy in Parkinson’s disease and atypical parkinsonisms.

R. Infante, G. Rizzo, A. Incensi, C. Scaglione, S. Capellari, V. Donadio, R. Liguori (Bologna, Italy)
SLC6A4 repeat and single-nucleotide polymorphisms are associated with depression and rest tremor in Parkinson’s disease

X. Zhang, M. Zou, R. Liu, J. Wang, Q. Fan (Wenzhou, China)
Sleep Aspects on Video-Polysomnography in P.A53T SNCA Mutation Carriers

AM. Simitsi, C. Koros, M. Stamelou, D. Papadimitrioy, A. Bougea, I. Pachi, N. Papagiannakis, R. Antonelou, E. Angelopoulou, K. Lourentzos, L. Stefanis, A. Bonakis (Athens, Greece)
Sleep disordered breathing and REM sleep behavior disorder in military Veterans with Parkinson’s disease

A. Sarwar, S. Moore (Houston, TX, USA)
Sleep Disturbances in Essential Tremor: A pilot investigation of the related brain microstructural changes using diffusion tensor imaging

YIL. Sengul, HAF. Otcu, ISM. Ustun, HAK. Sengul, ALP. Alkan (Istanbul, Turkey)
Sleep quality in Turkish patients with Parkinson’s disease

E. Tur, M. Demir, G. Kenangil, F. Domaç (Istanbul, Turkey)
Sleep-related quality of life predictors in Parkinson’s disease

D. Martínez-Roque, S. Castillo-Torres, C. Cerda-Contreras, I. Estrada-Bellmann, B. Chávez-Luévanos (Monterrey, Mexico)
Slow-Motion Analysis of Repetitive Tapping (SMART): a pilot study of a new measurement of bradykinesia

C. Simonet, MA. Galmes, J. Bestwick, A. Schrag, A. Lees, AJ. Noyce (London, United Kingdom)
Smartphone Applications Are Promising Modalities for Monitoring Parkinson’s Disease (PD) Symptoms

M. Qazi, H. Ellsworth, J. Chou, F. Wang, N. Hellmers, C. Henchcliffe, H. Sarva (Ny, NY, USA)
Smartphone software for home monitoring of motor symptoms in Parkinson’s disease – The CloudUPDRS Smartphone Software in Parkinson’s (CUSSP) study

E. Menozzi, A. Jha, R. Oyekan, S. Schreglmann, A. Latorre, E. Mulroy, G. Roussos, C. Stamate, I. Daskalopoulos, J. Rothwell, K. Bhatia (London, United Kingdom)
Smartphone-based gait assessment of psychiatric patients on neuroleptics

S. Hassin-Baer, T. Fay-Karmon, V. Livneh, S. Israeli-Korn, Y. Rubel, K. Tchelet, Z. Yekutieli, M. Linder, H. Yahalom, G. Yahalom (Ramat-Gan, Israel)
Smell and taste in cervical dystonia: a contribution to understand dystonia pathophysiology.

T. Herr, T. Hummel, M. Vollmer, C. Willert, B. Lehnert, M. Kronenbürger (Greifswald, Germany)
SNCA G51D missense mutation causing juvenile onset Parkinson’s disease

C. Cooper, J. Goldman, C. Zabetian, I. Mata, J. Leverenz (Chicago, IL, USA)
SNP assessment and gene expression analysis of alpha-synuclein (SNCA), LRRK2 gene and parkin (PRKN) gene in chewing tobacco exposures and find out the risk of Parkinson’s disease

R. Ramachandran, E. E, V. Uthayakumar (Erode, India)
Social Cognition and Habituation in Cervical Dystonia

B. Ellement, Y. Jasui, J. Sarna, S. Furtado, T. Pringsheim, B. Callahan, D. Martino (Calgary, AB, Canada)
Social cognition in Parkinson’s disease

L. Alonso-Recio, C. Merino, P. Martín, JM. Serrrano (Collado Villalba (madrid), Spain)
Social Cognition, Neuropsychological functioning & Mood Disorder in Cervical Dystonia (CD)

R. Monaghan, D. Mccormack, I. Ndukwe, T. Burke, N. Pender, S. O’Riordan, M. Hutchinson, F. O'Keeffe (Dublin, Ireland)
Social Network for the diagnosis of RLS

C. Guerra-Galicia, J. Blanco-Galina (San Luis Potosí, Mexico)
Social work support is associated with better health-related quality of life in late stage Parkinson’s disease

P. Gonzalez-Latapi, M. Rafferty, S. Wu, H. Chen, T. Simuni (Chicago, IL, USA)
Somatization disorder (SD) and Parkinson’s Disease (PD) in Mexican population

M. Rodriguez-Violante, A. Cervantes-Arriaga, A. Polo-Morales, A. Alcocer-Salas (Ciudad de México, Mexico)
Spastic ataxia and pseudo eye-of-the-tiger sign in a familiy with a novel compound heterozygous AFG3L2 mutations

G. Buda, S. Vishnopolska, J. Oliveri, F. Olivieri, G. Biagioli, L. Miquelini, A. Pellene, M. Marti, C. Calandra (Buenos Aires, Argentina)
Spastic Paraplegia Type 64: a Case Series

KCD. Donis, LAP. Paskulin, RBT. Tenório, JWR. Rocha, TOS. Silva, JMS. Saute (Porto Alegre, Brazil)
Spatial distribution of functional clusters coding for reward and movement information in the striatal direct and indirect pathways

MW. Jung, JH. Shin (Daejeon, Republic of Korea)
Spatial distribution of Parkinson’s disease in the Canton of Geneva, Switzerland

V. Fleury, R. Himsl, S. Joost, N. Nicastro, I. Guessous, P. Burkhard (Lausanne, Switzerland)
Special features of parkinsonism with congenital anomalies of cerebral vessels

AS. Norboboev, FAY. Odinaev, GUL. Rakhmatullaeva (Tashkent, Uzbekistan)
Specific chemosensory pattern in Parkinson’s disease

C. Tremblay, R. Emrich, A. Cavazzana, L. Klingelhoefer, M. Brandt, T. Hummel, A. Haehner, J. Frasnelli (Trois-Rivières, QC, Canada)
Specific SLC6A3 variant shows association with better memory in PD patients longitudinally

M. Ramezani, K. Martens, JS. Provost, I. Kathol, Z. Javer, J. Cheetham, E. Yoon, M. Kibreab, T. Hammer, ST. Lang, T. Alrazi, A. Robichaud, JR. Sarna, D. Martino, G. Pfeffer, O. Monchi (Calgary, AB, Canada)
Spectrum of motor complications in advanced Parkinson’s disease: data from a large Romanian case series evaluated for suitability for device aided therapy

J. Szász, V. Constantin, K. Orbán, L. Bancu, D. Georgescu, J. Szederjesi, A. Rácz, I. Mihály, S. Szatmári (Tirgu Mures, Romania)
Spectrum of Movement disorders in pediatric immune-mediated diseases

A. Saan, K. Linn, A. Minaye, C. Hlaing, K. Ko, H. Wintaung, N. Lin, Y. Wintaung (Yangon, Myanmar)
Spectrum of parkinsonian phenotypes associated with GCH1 mutation.

D. Al-Shorafat, A. Shetty, D. Munoz, A. Fasano, A. Lang (Toronto, ON, Canada)
Speculation on the timing of iron deposition in the putamen of patients with multiple system atrophy: multimodal MRI study

MJ. Lee, JH. Lee (Yangsan-Si, Republic of Korea)
Speech and language changes in cognitive impairment subtypes in patients with Parkinson´s disease

A. Kušnírová, Z. Košutzká, M. Hajdúk, M. Králová, M. Pápayová, M. Egryová, P. Valkovič, Z. Cséfalvay (Bratislava, Slovakia)
Speech and swallowing disorders in Parkinson’s disease – is there a link?

N. Madetko, S. Budrewicz (Wrocław, Poland)
Speech impairment as a marker of clinical changes in premanifest Huntington’s disease

J. Chan, Y. Lie, J. Stout, A. Vogel (Melbourne, Australia)
Spin turns and step turns in advanced Parkinson’s disease: a new clinical gait sign?

O. Gavriliuc, S. Paschen, A. Andrusca, C. Schlenstedt, G. Deuschl (Chisinau, Republic of Moldova)
Spinal Cord Stimulation for Severe Restless Leg Syndrome

C. Aquino, M. Zorn, S. Chamberlain, C. Bokat, P. Moretti, D. O'Dell (Salt Lake City, UT, USA)
Spinocerebellar ataxias in Southern Brazil: genotypic and phenotypic evaluation of 213 families

V. Rodrigues, F. Castilho Pelloso, A. Moro, S. Raskin, T. Ashizawa, F. Nascimento, C. Camargo, F. Germiniani, H. Teive (Curitiba, Brazil)
Spinocerebellar degeneration in Minami-Boso area of Japan – A hospital-based retrospective analysis

H. Shibayama, S. Akaike, K. Tajima, R. Takeuchi, F. Katada, S. Sato, T. Fukutaake, T. Matsukawa, H. Ishiura, S. Tsuji (Kamogawa, Japan)
Spiral Analysis Evaluates the Effects of Deep Brain Stimulation in Parkinson disease and Essential Tremor

S. Radmard, S. Pullman (New York, NY, USA)
Spiral loop width differentiates essential tremor and dystonic tremor

R. Rajan, R. Anandapadmanabhan, A. Saini, A. Srivastava (New Delhi, India)
Spoken Language Profiles in Parkinson’s Disease: A Potential ‘Biomarker’ of Cognitive Change?

A. Roberts (Evanston, IL, USA)
Spontaneous Pisa Syndrome in a Patient with Early-onset Alzheimer’s Disease

KA. Woo, D. Yoo, JY. Lee (Seoul, Republic of Korea)
Spontaneous volume regression of a brain cyst after DBS surgery

J. Hanuška, D. Urgošík, F. Růžička, R. Jech (Prague, Czech Republic)
Sporadic progressive ataxia and palatal tremor: A case report

Y. Liu, Y. Chen, Y. Chang (Kaohsiung City, Taiwan)
Stability and reliability of objective measures of speech in Parkinson’s Disease over 12 months

M. Magee, J. Tamplin, C. Marigliani, F. Baker, M. Morris, A. Vogel (Melbourne, Australia)
Startle Reflex as a possible biomarker associated with REM sleep behavior disorders in the prodromal stage of Parkinson’s disease

F. Traccis, M. Puligheddu, M. Figorilli, M. Carta, P. Devoto, G. Giua, ML. Fantini, D. Pani, M. Bortolato, R. Frau (Monserrato, Italy)
STAT-ON: a Wearable Inertial System to Objectively Evaluate Motor Symptoms in Parkinson’s Disease

D. Rodriguez-Martin, C. Pérez-López, A. Samà, M. Pié, A. Català, J. Cabestany, A. Rodríguez-Molinero (Vilanova I Geltrú, Spain)
Steering the Volume of Tissue Activated with Directional Deep Brain Stimulation Lead in the Globus Pallidus internus

S. Zhang, E. Pereira, N. Pouratian, A. Kent, B. Cheeran, L. Venkatesan, A. Schnitzler (Plano, TX, USA)
Stereopsis as a Visual Biomarker for Parkinson’s Disease

T. Sang, J. Fatehi, E. Mostofi, B. Zheng, F. Ba (Edmonton, AB, Canada)
Stereotactic Lesioning of Nucleus Accumbens for Treatment of Aggression in Mental Retardation

N. Durmaz çelik, M. Vural, S. özkan (Eskisehir, Turkey)
Steroid responsive chorea in Moyamoya disease: illustrative cases

S. Medarametla, N. Boraiah, S. Swamy, S. Raju (Bangalore, India)
Steroid-responsive myoclonus in the context of pembrolizumab treatment: a novel neurological phenotype.

M. Murphy, S. O'Dowd, M. Alexander (Dublin, Ireland)
Stiff Limb Syndrome Masquerading As a Focal Limb Dystonia

P. Morrison, R. Barbano (Rochester, NY, USA)
Stiff Limb Syndrome Progressing to Stiff Man Syndrome in a non-diabetic man

T. Ali, D. Ginjupally, Z. Guduru (Lexington, KY, USA)
Stiff-Person Syndrome and Limbic Encephalopathy Associated With GAD-antibody: A Case Report

SL. Li, YM. Yang, HZ. Guan, XH. Wan, HT. Ren (Peking, China)
Stigma and Quality of life in Parkinson’s disease patients on different treatment regimens

O. Vanta, L. Perju-Dumbrava, L. Perju-Dumbrava (Cluj-Napoca, Romania)
Stigma in Egyptian patients with Parkinson’s disease

M. Salim, A. Helmy, A. Shalash, E. Abdel Dayem (Cairo, Egypt)
Stimulation challenge test after STN DBS improves postoperative satisfaction in patients with Parkinson’s Disease

V. Geraedts, J. van Hilten, J. Marinus, A. Mosch, K. Naarding, C. Hoffmann, N. Vd Gaag, MF. Contarino (Leiden, Netherlands)
Stimulation Frequency and Active Contact Location Influence Speech Problems in Parkinson’s Disease Patients with Bilateral Subthalamic Deep Brain Stimulation

O. Phokaewvarangkul, K. Boonpang, R. Bhidayasiri (Bangkok, Thailand)
Stimulation of the Left Anterior Sensorimotor Subthalamic Nucleus Improves Voice Function in Parkinson’s Disease

A. Jorge, C. Dastolfo-Hromack, W. Lipski, I. Kratter, L. Smith, J. Gartner-Schmidt, R. Richardson (Pittsburgh, PA, USA)
Stimulus-induced paroxysmal cranial dyskinesia and Nail Patella Syndrome in a multigenerational family with a novel mutation in the LMX1B gene

S. Bech, A. Loekkegaard, T. Nielsen, A. Nørremølle, L. Hasholt, Y. Mang, J. Nielsen, H. Eiberg, L. Hjermind (Copenhagen, Denmark)
STN-DBS programing for dyskinesia: a case report

L. Li, Y. Zhang (Beijing, China)
Strategies for Implementation of a Quality Improvement Registry for DBS in Parkinson’s Disease

J. Jimenez-Shahed, P. D'Haese, J. Kirk, M. York, A. Berg, L. Shih, J. Schwalb, J. Mcinerney (Houston, TX, USA)
Strategies to minimize complications in deep brain stimulation in a series of 240 DBS procedures

C.. Matthies, R.. Nickl, P.. Capetian, J.. Volkmann, R-I. Ernestus, P. Fricke (Wuerzburg, Germany)
Striatal dopaminergic dysregulation and dystonia-like movements induced by peripheral nerve crush in a transgene DYT1 mouse model

L. Rauschenberger, A. Stengl, S. Knorr, K. Grundmann-Hauser, J. Volkmann, CW. Ip (Würzburg, Germany)
Striatal dopaminergic regulation of micrographia in parkinsonism

M. Eklund, J. Joutsa, S. Nuuttila, E. Mäkinen, E. Jaakkola, T. Noponen, T. Ihalainen, M. Koivisto, S. Teperi, F. Scheperjans, V. Kaasinen (Turku, Finland)
Structural and functional MRI brain alterations of Lewy body diseases

O. Lucas-Jiménez, N. Ibarretxe-Bilbao, N. Ojeda, J. Peña, A. Cabrera-Zubizarreta, A. Murueta-Goyena, JC. Gómez-Esteban, I. Gabilondo (Bilbao, Spain)
Structural changes in non-manifesting GBA mutation carriers and GBA mutation carriers with Parkinson’s disease

T. Yousaf, M. Kershaw, V. Suarez Contreras, P. Vickers, G. Pagano, M. Politis (London, United Kingdom)
Structural connectivity changes in G2019S-LRRK2 gene mutation carriers without manifest Parkinson’s disease

G. Pagano, P. Vickers, J. Schulz, H. Wilson, M. Politis (London, United Kingdom)
Structural connectivity changes in prodromal Parkinson’s disease patients: a multimodal MRI study

V. Suarez Contreras, G. Pagano, J. Fernandez Bonfante, H. Wilson, M. Politis (London, United Kingdom)
Structural Connectivity Predicts Clinical Outcomes of Deep Brain Stimulation for Tourette Syndrome

K. Johnson, G. Duffley, D. Servello, A. Bona, M. Porta, J. Ostrem, E. Bardinet, M-L. Welter, A. Lozano, J. Baldermann, J. Kuhn, D. Huys, T. Foltynie, M. Hariz, E. Joyce, L. Zrinzo, Z. Kefalopoulou, J-G. Zhang, F-G. Meng, CC. Zhang, Z. Ling, X. Xu, X. Yu, A. Smeets, L. Ackermans, V. Visser-Vandewalle, A. Mogilner, M. Pourfar, L. Almeida, A. Gunduz, W. Hu, K. Foote, M. Okun, C. Butson (Salt Lake City, UT, USA)
Structural connectome of brainstem nuclei in REM sleep behavior disorder, a model of premanifest synucleinopathy

MG. García-Gomar, LD. Lewis, L. Wald, B. Rosen, A. Videnovic, M. Bianciardi (Boston, MA, USA)
Structural imaging changes in hepatic and neurological Wilson disease

A. Patel, K. Nalamada, A. Vives-Rodriguez, D. Robakis, T. Constable, J. Arora, M. Schilsky, S. Tinaz (New Haven, CT, USA)
Structural network fingerprints for GPI-DBS in dystonia

G. Gonzalez-Escamilla, M. Muthuraman, M. Reich, N. Koirala, C. Riedel, M. Glaser, F. Lange, G. Deuschl, J. Volkmann, S. Groppa (Mainz, Germany)
Study of cardiac sympathetic denervation by 18F-FDOPA PET-CT Imaging in early Parkinson disease (EPD) and Atypical parkinsonian syndromes (APS)

K C. Chudasama, VG. Goyal, C P. Patel, MV. Srivastava, MBS. Singh, MT. Tripathi, VY. Y, AR. Roy (Delhi, India)
Study of Epidemiological Risk Factors in a Male-Only North Indian Parkinson’s Cohort

K. Shukla, N. Sawal (Chandigarh, India)
Study of eye movements as a tool in the diagnosis hereditary ataxias

D. Gasca Saldaña, Y. Sánchez Jimenez, MC. Boll (Mexico City, Mexico)
Study of prevalence of Axis-1 DSM-4 psychiatric disorders in patients with parkinsonism in a rural movement disorder clinic in Western India

D. Desai, S. Singh, S. Desai (Anand, India)
Study on the effect of levodopa administration on serum zinc levels in Parkinson’s disease patients

H. Matsuyama, K. Matsuura, H. Ishikawa, Y. Hirata, N. Kato, A. Niwa, Y. Narita, H. Tomimoto (Tsu, Japan)
Subacute Encephalopathy with Pimavanserin Treatment in Parkinson Disease

J. King, G. Volkell, J. Wyant, E. Molho (Albany, NY, USA)
Subchronic copper exposure induces parkinsonism in rats: Neuromodulatory potential of curcumin

A. Abbaoui, H. Gamrani (Marrakech, Morocco)
Subcortical atrophy is an early event in Huntington’s disease

N. Rocha, L. Latham, O. Charron, G. Papadimitropoulos, G. Colpo, L. Freeman, E. Furr Stimming, A. Teixeira (Houston, TX, USA)
Substantia Nigra (SN) Hyperechogenicity as seen in Transcranial Sonography (TCS) is a reliable disease progression marker from Stage I to Stage II in Early Onset Parkinson’s Disease (EOPD)

S. Ravi, V. Shivkumar, D. Dang, T. Gilmour, A. Espay, J. Wang, T. Subramanian, K. Venkiteswaran (Hershey, PA, USA)
Substantia Nigra Hyperechogenicity in Parkinson’s Disease and Essential Tremor and its Association with Premotor Symptoms of Parkinson’s Disease

M. Uribe Roca, A. Chertcoff, L. Bandeo, M. Saucedo, F. Pantiu, L. de Francesco, L. Leon Cejas, M. Pacha, G. Napoli, P. Bonardo, O. Martinez, M. Fernandez Pardal, R. Reisin (Buenos Aires, Argentina)
Subthalamic Neurons Fire Differently In Planned Versus Reactive Movements

A. Fazl, K. Katlowitz, M. Pourfar, A. Mogilner, D. London (Livingston, NJ, USA)
Subthalamic Nucleus of Luys: A review. What has evolved since 1865?

G. Froehner, A. Meira, F. Germiniani, M. Meneses, R. Munhoz, H. Teive (Curitiba, Brazil)
Successful altruistic living kidney donation in a patient with Huntington’s disease

C. Cooper, S. Chen, B. Bernard, J. Goldman (Chicago, IL, USA)
Successful late rehabilitation based on botulinum therapy

T. Kuznetsova, A. Svetkina (Samara, Russian Federation)
Successful Treatment of Orthostatic Tremor using Perampanel

A. Wadhwa, S. Schaefer (New Haven, CT, USA)
Successful treatment of Parkinson’s disease-related impulse control disorder with bilateral STN DBS

T. Stiep, D. Spengler Shpiner, C. Luca (Miami, FL, USA)
Successful treatment of secondary dystonia with deep brain stimulation of the globus pallidus internus

S. Hendrickx, PH. Bourgeois, A. Tieleman, D. Vanhauwaert, T. Couvreur, O. van Damme (Roeselare, Belgium)
Sudden alopecia secondary to levodopa treatment

N. Garcia Alvarado, N. López Ariztegui, MI. Morales Casado, JC. Segundo Rodríguez, C. Schoendorff Ortega, R. Almansa Castillo, JA. Perez Matos, A. ávila Fernández, C. Marsal Alonso (Toledo, Spain)
Super-urgent liver transplantation for a 62 year old with Wilson’s disease presenting with acute liver failure

S. Shribman, A. Shenoy, W. Griffiths, A. Gimson, T. Warner (London, United Kingdom)
Supportive treatments for Ataxia, a Randomized Control Trial

MIA. Arain (Jamshoro, Pakistan)
Surgery‐related 30-day morbidity of deep brain stimulation in a large cohort of 600 patients

J. Runge, A. Saryyeva, C. Blahak, C. Schrader, H. Bäzner, HH. Capelle, M. Abdallat, M. Wolf, TM. Kinfe, JK. Krauss (Hannover, Germany)
Survival estimates for Spinocerebellar Ataxia type 2 based on age at onset and CAG repeats length

L. Almaguer-Mederos, R. Aguilera-Rodríguez, Y. González-Zaldívar, D. Almaguer-Gotay, D. Cuello-Almarales, Y. Vázquez-Mojena, L. Velásquez-Pérez (Holguín, Cuba)
Sustained Functional Benefits After a Single Injection with AbobotulinumtoxinA Using a 2mL Injection Volume in Adults with Cervical Dystonia

A. Patel, M. Lew, A. Brashear, K. Dashtipour, S. Isaacson, R. Hauser, W. Ondo, P. Maisonobe, J. Otto (Overland Park, KS, USA)
Sustained mutant huntingtin lowering in the brain and cerebrospinal fluid of Huntington disease minipigs mediated by AAV5-miHTT gene therapy

A. Vallès-Sanchez, A. Stam, C. Brouwers, J. Klíma, B. Bohuslavová, R. Pintauro, M. Sogorb-Gonzalez, L. Paerels, V. Fodale, A. Bresciani, Z. Ellederová, B. Blits, J. Motlik, S. van Deventer, M. Evers, P. Konstantinova (Amsterdam, Netherlands)
Sustained release triple drug loaded Microbaloons for management of Parkinson’s Disease

S. Bhargava (Prayagraj, India)
Swallowing assessment in Parkinson’s Disease using Dynamic Magnetic Resonance Imaging (dMRI)

SG. Gudwani, PU. Upadhyay, KS. Sharma, RS. Sagar, SSK. Kumaran, RKD. Dhamija (New Delhi, India)
SWALLOWING VIDEOENDOSCOPY IN PATIENTS WITH PARKINSON’S DISEASE WITH DEEP BRAIN STIMULATION

T. Alves, N. Oliveira, G. Diaféria, M. Palumbo, MG. Ghilardi, E. Fonoff, M. Padovani (São Paulo, Brazil)
Switching entacapone ‘non-responders’ to open-label opicapone: change in absolute OFF-time following the 1-year extension BIPARK-I study

J. Ferreira, A. Lees, W. Poewe, O. Rascol, A. Santos, D. Magalhães, J. Rocha, P. Soares-da-Silva (Lisbon, Portugal)
Sydenham’s chorea: Clinical features and treatment outcome

S. Pandey, P. Rani (New Delhi, India)
Symptomatic delayed-onset edema following deep brain stimulation for Parkinson’s disease: occurrence, symptoms, management and outcomes. Experience of a single center.

B. Minafra, NG. Pozzi, M. Picascia, R. Zangaglia, F. Bruschi, F. Avantaggiato, M. Todisco, D. Servello, C. Pacchetti (Pavia, Italy)
Symptomatic palatal tremor combined with unilateral limb tremor and parkinsonism

SK. Song, JH. Kang (Jeju-Si, Republic of Korea)
Symptomatic treatment of hereditary spastic paraplegias with fampridine: a pilot study

M. Rosário, J. Ferreira, J. Ferro, L. Guedes (Lisbon, Portugal)
Synaptic dysfuncion in a Drosophila model of PARK14

T. Hatano, A. Mori, T. Inoshita, K. Fukushima-Shiba, T. Koinuma, C. Yamashita, Y. Imai, N. Hattori (Tokyo, Japan)
Synaptic function in Parkinson’s disease associated with GBA mutations

T. Eid, R. Bandopadhyay, T. Lashley, J. Hardy, J. Holton, T. Warner, P. Francis (London, United Kingdom)
Synchronization Study of Regional Local Field Potential in Rat with Dopamine Receptor Stimulation

SH. Lin, SY. Chen, YY. Chen (Hualien, Taiwan)
Synuclein-alpha´s variant, rs 894280 shows association with memory and attention in PD patients

O. Monchi, JR. Sarna, D. Martino, Z. Gan-Or, JA. Ruskey, T. Alrazi, A. Robichaud, T. Hammer, ST. Lang, J. Cheetham, E. Yoon, M. Kibreab, I. Kathol, JS. Provost, M. Ramezani (Calgary, AB, Canada)
Systematic Assessment of 10 diagnostic marker candidates in biological fluids for Parkinson’s disease

B. Mollenhauer, R. Gera, N. Kruse, R. Barbour, W. Zago, S. Schade, B. Otte, C. Trenkwalder (South San Francisco, CA, USA)
Systematic review of Mucuna Pruriens as a treatment for Parkinson’s disease

TH. Boonmongkol, O. Phokaewvarangkul, S. Vimolmangkang, R. Bhidayasiri (Bangkok, Thailand)
Systematic Review of Non-pharmacological Interventions for Respiratory Health in Parkinson’s Disease (PD)

L. Mcmahon, O. Lennon, C. Blake (Dublin, Ireland)